Cic edizioni internazionali
Research and Advances in Psychiatry

Vortioxetine: efficacy on cognitive symptoms in Major Depressive Disorder

Original Article, 50 - 54
Tag this article
Abstract
Enhanced HTML Full text PDF
In Major Depressive Disorder (MDD), cognitive impairment is frequently associated with depressive symptoms, overlapping them and not being just a consequence; moreover, it persists during remission periods.
Cognitive dysfunctions concern different areas: attention, concentration, executive functions, learning, memory, intellective processing speed, and decision making capacity.
Vortioxetine is a new generation antidepressant with a multimodal action mechanism and a receptor profile that enable it to operate on different neurotransmitter systems. Its administration causes an increase of the glutamatergic, cholinergic, histaminergic and noradrenergic tone, particularly in areas involved in cognitive functions, such as Prefrontal Cortex and Hippocampus.
It also causes increasing neurogenesis, activation of coding genes for dendritic spines, dendritic arborization, increased long-term enhancement of hippocampus.
The aim of our work is to better understand its mechanism of action and to summarize the most recent literature data.

Vol. 4 (No. 3) 2017 September-December

  1. Cynicism in the culture of psychonauts: a Foucauldian-inspired comparative analysis
    Kelemen G., Szijjarto L., Vojtek E., Erdos M.B.
  2. Anhedonia and positive affect in depressed patients. A qualitative overview
    Sarchione F., Rucco A., Stigliano G., Campese O., Di Giannantonio M.
  3. Vortioxetine: efficacy on cognitive symptoms in Major Depressive Disorder
    Escelsior A., Aguglia A., Cervetti A., Nebbia J., Pacella S., Piccinini G., Visimberga S., Amore M., Prestia D.
  4. rTMS of the left DLPFC awakens hedonic response in cocaine addiction: a case report
    Martinotti G., Pettorruso M., De Risio L., Montemitro C., Fanella F., Janiri L., Di Giannantonio M.
  5. Current challenges of synthetic cannabinoids: clinical and psychopathological aspects
    Prilutskaya M., Elgharably Y., Corazza O.
Last Viewed articles: la lista degli ultimi x visitati.
  1. Vortioxetine: efficacy on cognitive symptoms in Major Depressive Disorder
    Escelsior A., Aguglia A., Cervetti A., Nebbia J., Pacella S., Piccinini G., Visimberga S., Amore M., Prestia D.
credits